Information & Marketing
We satisfy legitimate interests in information about our innovative products and services
As a research-focused healthcare company, Roche creates, produces and markets innovative diagnostic and therapeutic products and services that provide significant benefits. Our stakeholders have a legitimate interest in being informed about our products and services, including the results of our research and development activities.
We provide this information in a transparent, accurate and timely way to enable interested parties to take advantage of any progress we have achieved in medical science. We are committed to complying with all applicable laws, regulations, industry codes and internal Roche processes and standards relating to good marketing practices. We support the medical education of healthcare professionals in a responsible way.
Roche’s interactions with healthcare professionals and healthcare organisations are aimed at exchanging scientific information that can help optimise the use of Roche’s products and services. These interactions are based on standards of ethics, integrity and fair remuneration for services.
Roche respects the legitimate undertakings of its competitors, including generic and biosimilar manufacturers. However, it is expected that they comply with applicable laws, regulations and industry codes. Roche does not tolerate misleading claims or disparaging of its products, and it protects its products and interests against unfair competition.
We are transparent with regard to our contributions to healthcare professionals and healthcare organisations and fully comply with all laws, regulations and industry codes requiring disclosure (e.g. US Sunshine Act, EFPIA Code of Practice, MedTech Europe Code of Ethical Business Practice). We publish further data on a voluntary basis globally and locally as part of our sustainability reporting.